GDTC

Quote

Short

News

Articles

Message Board

CytoMed Therapeutics Limited (NASDAQ : GDTC ) News

CytoMed Therapeutics Limited (NASDAQ: GDTC) News Releases

GDTC News Releases

February 05, 2026 03:30:25 pm

QM US Market Movers News

US Companies Moving the Markets, Evening edition
Thu, Feb 05, 2026 as of 4:00 pm ET

January 28, 2026 10:00:00 am

GlobeNewswire

CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

January 13, 2026 09:38:22 am

24/7 Market News

Morning Market Brief: From IP Land Grabs to FDA Greenlights, Small-Cap Innovation Takes Center Stage

January 13, 2026 08:00:00 am

GlobeNewswire

CytoMed Therapeutics' new year update and seeks shareholders' feedback on proposal to improve shareholder value for their patient capital

December 08, 2025 08:00:00 am

GlobeNewswire

CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia

November 18, 2025 08:00:00 am

GlobeNewswire

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

November 06, 2025 08:00:00 am

GlobeNewswire

CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy

October 22, 2025 08:46:01 am

SeekingAlpha

CytoMed Therapeutics' chairman increases effective holdings to 21.95%

October 22, 2025 08:00:00 am

GlobeNewswire

CytoMed Therapeutics' Chairman Increases Effective Holdings to 21.95%

October 15, 2025 08:47:35 am

Equity Insider

Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account